Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology-Reference-Cited by-同舟云学术

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Published:2022-06 Issue:6 Volume:20 Page:691-722
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Gradishar William J.¹,Moran Meena S.²,Abraham Jame³,Aft Rebecca⁴,Agnese Doreen⁵,Allison Kimberly H.⁶,Anderson Bethany⁷,Burstein Harold J.⁸,Chew Helen⁹,Dang Chau¹⁰,Elias Anthony D.¹¹,Giordano Sharon H.¹²,Goetz Matthew P.¹³,Goldstein Lori J.¹⁴,Hurvitz Sara A.¹⁵,Isakoff Steven J.¹⁶,Jankowitz Rachel C.¹⁷,Javid Sara H.¹⁸,Krishnamurthy Jairam¹⁹,Leitch Marilyn²⁰,Lyons Janice³,Mortimer Joanne²¹,Patel Sameer A.¹⁴,Pierce Lori J.²²,Rosenberger Laura H.²³,Rugo Hope S.²⁴,Sitapati Amy²⁵,Smith Karen Lisa²⁶,Smith Mary Lou²⁷,Soliman Hatem²⁸,Stringer-Reasor Erica M.²⁹,Telli Melinda L.⁶,Ward John H.³⁰,Wisinski Kari B.⁷,Young Jessica S.³¹,Burns Jennifer³²,Kumar Rashmi³²

Affiliation:

1. 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

2. 2Yale Cancer Center/Smilow Cancer Hospital;

3. 3Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

4. 4Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

5. 5The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

6. 6Stanford Cancer Institute;

7. 7University of Wisconsin Carbone Cancer Center;

8. 8Dana-Farber/Brigham and Women’s Cancer Center;

9. 9UC Davis Comprehensive Cancer Center;

10. 10Memorial Sloan Kettering Cancer Center;

11. 11University of Colorado Cancer Center;

12. 12The University of Texas MD Anderson Cancer Center;

13. 13Mayo Clinic Cancer Center;

14. 14Fox Chase Cancer Center;

15. 15UCLA Jonsson Comprehensive Cancer Center;

16. 16Massachusetts General Hospital Cancer Center;

17. 17Abramson Cancer Center at the University of Pennsylvania;

18. 18Fred Hutchinson Cancer Research Center/University of Washington;

19. 19Fred & Pamela Buffet Cancer Center;

20. 20UT Southwestern Simmons Comprehensive Cancer Center;

21. 21City of Hope National Medical Center;

22. 22University of Michigan Rogel Cancer Center;

23. 23Duke Cancer Institute;

24. 24UCSF Helen Diller Family Comprehensive Cancer Center;

25. 25UC San Diego Moores Cancer Center;

26. 26The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

27. 27Research Advocacy Network;

28. 28Moffitt Cancer Center;

29. 29O'Neal Comprehensive Cancer Center at UAB;

30. 30Huntsman Cancer Institute at the University of Utah;

31. 31Roswell Park Comprehensive Cancer Center; and

32. 32National Comprehensive Cancer Network.

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visitNCCN.org.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/20/6/article-p691.xml

Reference414 articles.

1. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications;Puglisi;Ann Oncol,2005

2. effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: a randomized phase 3 clinical trial;Kim;JAMA Oncol,2022

3. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer;Podoloff;J Natl Compr Canc Netw,2007

4. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer;Giuliano;JAMA,2011

5. effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: a randomized phase 3 clinical trial;Kim;JAMA Oncol,2022

Cited by 322 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Value of Metabolic Parameters in Pretreatment 18F-FDG PET/CT with Regard to Molecular Subtype, Immunohistochemistry, and Overall Survival in Primary Invasive Ductal Breast Cancer;TURK ONCOL DERG;2024

2. Axillary management in breast cancer after neoadjuvant chemotherapy in the modern era: A national cancer database analysis;Surgery;2024-03

3. Using MammaPrint on core needle biopsy to guide the need for axillary staging during breast surgery;Surgery;2024-03

4. Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: A single-center study;2024-02-06

5. Current Status of Imaging for Breast Cancer Staging;Current Breast Cancer Reports;2024-02-06